Immuno-Oncology Market is poised to value over USD 160 billion by 2028 end at a CAGR of over 11.8% during the forecast period 2021 to 2028. Cancer immunotherapy, also known as immuno-oncology, is a method of treating cancer by using the body's own immune system to stop, eliminate, and control the disease.
